Skip to main content
Top
Published in: Sleep and Breathing 1/2017

01-03-2017 | Sleep Breathing Physiology and Disorders • Review

The effects of topical nasal steroids on continuous positive airway pressure compliance in patients with obstructive sleep apnea: a systematic review and meta-analysis

Authors: Natamon Charakorn, Prakobkiat Hirunwiwatkul, Naricha Chirakalwasan, Busarakum Chaitusaney, Mantana Prakassajjatham

Published in: Sleep and Breathing | Issue 1/2017

Login to get access

Abstract

Objectives

The purpose of the study was to conduct a systematic review and meta-analysis in patients with obstructive sleep apnea (OSA), evaluating effects of topical nasal steroids on continuous positive airway pressure (CPAP) machine use and nasal symptoms.

Search methods

Data source: A comprehensive search of Pubmed, Scopus, Web of Science, and the Cochrane Library was performed through April 2016. Manual searches and subject matter expert input were also obtained. Studies assessing effects of nasal steroids on CPAP machine use in adults, which reported quantitative outcome data of CPAP compliance, were included.

Results

Two studies (144 patients) met inclusion criteria. Both were randomized, placebo-controlled clinical trials (RCT). Pooled fixed effects analysis did not identify a statistically significant difference between both the groups for average duration of CPAP machine use per night. But there was an overall increase in the usage of 0.4 h (95 % confidence interval (CI) (−0.20, 1.00); P = 0.19) in favor of nasal steroids. Difference of percentage of nights with CPAP use was not demonstrated (mean difference 0.06, 95 % CI (−0.27, 0.39); P = 0.71). There was also no significant difference in nasal symptoms (mean difference 0.63, 95 % CI (−0.11, 1.36), P = 0.1).

Conclusion

Nasal steroids showed benefits on CPAP use, but did not reach statistical significance. Data was based on meta-analysis of RCTs of 4-week follow-up in unselected OSA patients. Future controlled studies with selected group and longer follow-up duration are needed to confirm the benefits of nasal steroid on CPAP compliance in OSA patients.
Literature
1.
go back to reference Kushida CA, Littner MR, Hirshkowitz M, Morgenthaler TI, Alessi CA, Bailey D, Boehlecke B, Brown TM, Coleman J Jr, Friedman L, Kapen S, Kapur VK, Kramer M, Lee-Chiong T, Owens J, Pancer JP, Swick TJ, Wise MS, American Academy of Sleep M (2006) Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep 29(3):375–380CrossRefPubMed Kushida CA, Littner MR, Hirshkowitz M, Morgenthaler TI, Alessi CA, Bailey D, Boehlecke B, Brown TM, Coleman J Jr, Friedman L, Kapen S, Kapur VK, Kramer M, Lee-Chiong T, Owens J, Pancer JP, Swick TJ, Wise MS, American Academy of Sleep M (2006) Practice parameters for the use of continuous and bilevel positive airway pressure devices to treat adult patients with sleep-related breathing disorders. Sleep 29(3):375–380CrossRefPubMed
2.
go back to reference He J, Kryger MH, Zorick FJ, Conway W, Roth T (1988) Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest 94(1):9–14CrossRefPubMed He J, Kryger MH, Zorick FJ, Conway W, Roth T (1988) Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest 94(1):9–14CrossRefPubMed
4.
go back to reference Antic NA, Catcheside P, Buchan C, Hensley M, Naughton MT, Rowland S, Williamson B, Windler S, McEvoy RD (2011) The effect of CPAP in normalizing daytime sleepiness, quality of life, and neurocognitive function in patients with moderate to severe OSA. Sleep 34(1):111–119PubMedPubMedCentral Antic NA, Catcheside P, Buchan C, Hensley M, Naughton MT, Rowland S, Williamson B, Windler S, McEvoy RD (2011) The effect of CPAP in normalizing daytime sleepiness, quality of life, and neurocognitive function in patients with moderate to severe OSA. Sleep 34(1):111–119PubMedPubMedCentral
6.
go back to reference Kreivi HR, Virkkula P, Lehto J, Brander P (2010) Frequency of upper airway symptoms before and during continuous positive airway pressure treatment in patients with obstructive sleep apnea syndrome. Respiration 80(6):488–494. doi:10.1159/000321371 CrossRefPubMed Kreivi HR, Virkkula P, Lehto J, Brander P (2010) Frequency of upper airway symptoms before and during continuous positive airway pressure treatment in patients with obstructive sleep apnea syndrome. Respiration 80(6):488–494. doi:10.​1159/​000321371 CrossRefPubMed
8.
go back to reference Staevska MT, Mandajieva MA, Dimitrov VD (2004) Rhinitis and sleep apnea. Curr Allergy Asthma Rep 4(3):193–199CrossRefPubMed Staevska MT, Mandajieva MA, Dimitrov VD (2004) Rhinitis and sleep apnea. Curr Allergy Asthma Rep 4(3):193–199CrossRefPubMed
11.
go back to reference Ryan S, Doherty LS, Nolan GM, McNicholas WT (2009) Effects of heated humidification and topical steroids on compliance, nasal symptoms, and quality of life in patients with obstructive sleep apnea syndrome using nasal continuous positive airway pressure. J Clin Sleep Med 5(5):422–427PubMedPubMedCentral Ryan S, Doherty LS, Nolan GM, McNicholas WT (2009) Effects of heated humidification and topical steroids on compliance, nasal symptoms, and quality of life in patients with obstructive sleep apnea syndrome using nasal continuous positive airway pressure. J Clin Sleep Med 5(5):422–427PubMedPubMedCentral
13.
go back to reference Juniper EF, Thompson AK, Ferrie PJ, Roberts JN (2000) Development and validation of the mini Rhinoconjunctivitis Quality of Life Questionnaire. Clin Exp Allergy 30(1):132–140CrossRefPubMed Juniper EF, Thompson AK, Ferrie PJ, Roberts JN (2000) Development and validation of the mini Rhinoconjunctivitis Quality of Life Questionnaire. Clin Exp Allergy 30(1):132–140CrossRefPubMed
14.
go back to reference Wiseman LR, Benfield P (1997) Intranasal fluticasone propionate. A reappraisal of its pharmacology and clinical efficacy in the treatment of rhinitis. Drugs 53(5):885–907CrossRefPubMed Wiseman LR, Benfield P (1997) Intranasal fluticasone propionate. A reappraisal of its pharmacology and clinical efficacy in the treatment of rhinitis. Drugs 53(5):885–907CrossRefPubMed
15.
go back to reference Morris LG, Setlur J, Burschtin OE, Steward DL, Jacobs JB, Lee KC (2006) Acoustic rhinometry predicts tolerance of nasal continuous positive airway pressure: a pilot study. Am J Rhinol 20(2):133–137PubMed Morris LG, Setlur J, Burschtin OE, Steward DL, Jacobs JB, Lee KC (2006) Acoustic rhinometry predicts tolerance of nasal continuous positive airway pressure: a pilot study. Am J Rhinol 20(2):133–137PubMed
16.
go back to reference Parikh NG, Junaid I, Sheinkopf L, Randhawa I, Santiago SM, Klaustermeyer WB (2014) Clinical control in the dual diagnosis of obstructive sleep apnea syndrome and rhinitis: a prospective analysis. Am J Rhinol Allergy 28(1):e52–e55. doi:10.2500/ajra.2014.28.3977 CrossRefPubMed Parikh NG, Junaid I, Sheinkopf L, Randhawa I, Santiago SM, Klaustermeyer WB (2014) Clinical control in the dual diagnosis of obstructive sleep apnea syndrome and rhinitis: a prospective analysis. Am J Rhinol Allergy 28(1):e52–e55. doi:10.​2500/​ajra.​2014.​28.​3977 CrossRefPubMed
19.
go back to reference Johnson M (1998) Development of fluticasone propionate and comparison with other inhaled corticosteroids. J Allergy Clin Immunol 101(4 Pt 2):S434–S439CrossRefPubMed Johnson M (1998) Development of fluticasone propionate and comparison with other inhaled corticosteroids. J Allergy Clin Immunol 101(4 Pt 2):S434–S439CrossRefPubMed
20.
go back to reference Corren J (1999) Intranasal corticosteroids for allergic rhinitis: how do different agents compare? J Allergy Clin Immunol 104(4 Pt 1):S144–S149CrossRefPubMed Corren J (1999) Intranasal corticosteroids for allergic rhinitis: how do different agents compare? J Allergy Clin Immunol 104(4 Pt 1):S144–S149CrossRefPubMed
22.
go back to reference Ballard RD, Gay PC, Strollo PJ (2007) Interventions to improve compliance in sleep apnea patients previously non-compliant with continuous positive airway pressure. J Clin Sleep Med 3(7):706–712PubMedPubMedCentral Ballard RD, Gay PC, Strollo PJ (2007) Interventions to improve compliance in sleep apnea patients previously non-compliant with continuous positive airway pressure. J Clin Sleep Med 3(7):706–712PubMedPubMedCentral
23.
24.
go back to reference Constantinidis J, Knobber D, Steinhart H, Kuhn J, Iro H (2000) Fine-structural investigations of the effect of nCPAP-mask application on the nasal mucosa. Acta Otolaryngol 120(3):432–437CrossRefPubMed Constantinidis J, Knobber D, Steinhart H, Kuhn J, Iro H (2000) Fine-structural investigations of the effect of nCPAP-mask application on the nasal mucosa. Acta Otolaryngol 120(3):432–437CrossRefPubMed
25.
go back to reference Mador MJ, Krauza M, Pervez A, Pierce D, Braun M (2005) Effect of heated humidification on compliance and quality of life in patients with sleep apnea using nasal continuous positive airway pressure. Chest 128(4):2151–2158. doi:10.1378/chest.128.4.2151 CrossRefPubMed Mador MJ, Krauza M, Pervez A, Pierce D, Braun M (2005) Effect of heated humidification on compliance and quality of life in patients with sleep apnea using nasal continuous positive airway pressure. Chest 128(4):2151–2158. doi:10.​1378/​chest.​128.​4.​2151 CrossRefPubMed
26.
go back to reference Saka C, Vuralkan E, Firat IH, Alicura S, Hucumenoglu S, Akin I, Ardic S, Gokler A (2012) The effects of CPAP treatment on nasal mucosa in patients with obstructive sleep apnea. Eur Arch Otorhinolaryngol 269(9):2065–2067. doi:10.1007/s00405-011-1906-2 CrossRefPubMed Saka C, Vuralkan E, Firat IH, Alicura S, Hucumenoglu S, Akin I, Ardic S, Gokler A (2012) The effects of CPAP treatment on nasal mucosa in patients with obstructive sleep apnea. Eur Arch Otorhinolaryngol 269(9):2065–2067. doi:10.​1007/​s00405-011-1906-2 CrossRefPubMed
Metadata
Title
The effects of topical nasal steroids on continuous positive airway pressure compliance in patients with obstructive sleep apnea: a systematic review and meta-analysis
Authors
Natamon Charakorn
Prakobkiat Hirunwiwatkul
Naricha Chirakalwasan
Busarakum Chaitusaney
Mantana Prakassajjatham
Publication date
01-03-2017
Publisher
Springer Berlin Heidelberg
Published in
Sleep and Breathing / Issue 1/2017
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-016-1375-3

Other articles of this Issue 1/2017

Sleep and Breathing 1/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine